Your browser doesn't support javascript.
loading
New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?
Wilson, Leslie; Tang, Jun; Zhong, Lixian; Balani, Gregory; Gipson, Gregory; Xiang, Pin; Yu, Dawn; Srinivas, Sandy.
Afiliação
  • Wilson L; Department of Clinical Pharmacy, University of California, San Francisco, CA, USA WilsonL@pharmacy.ucsf.edu.
  • Tang J; Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.
  • Zhong L; Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.
  • Balani G; Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.
  • Gipson G; Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.
  • Xiang P; Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.
  • Yu D; Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.
  • Srinivas S; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
J Oncol Pharm Pract ; 20(6): 417-25, 2014 Dec.
Article em En | MEDLINE | ID: mdl-24243919
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Taxoides / Neoplasias de Próstata Resistentes à Castração / Androstenos Tipo de estudo: Clinical_trials / Health_economic_evaluation / Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Taxoides / Neoplasias de Próstata Resistentes à Castração / Androstenos Tipo de estudo: Clinical_trials / Health_economic_evaluation / Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article